Absolute Genomics

We are excited to invite you for our 5th webinar on “Pharmacogenomic testing for personalized treatment” on November 30, 2022, at 12:00 PM EST.

About this webinar:

Pharmacogenomic testing (PGx) can optimize and individualize medication therapy to each patient, removing the one-size-fits-all approach of current practice. The ability to predict patient responses to medications via genetic testing has the potential to decrease adverse side effects, reducing costs to both the patient and health care system. Occurrence of fewer side effects improves compliance, which leads to improved patient outcomes and overall provider and patient satisfaction.



Designed For

Physicians, nurse practitioners, physician assistants, pharmacists, nurses, fellows, residents, students and other interested health care professionals



Provided By

Absolute Genomics Laboratory



Objectives

Define pharmacogenomics and discuss clinical significance
Identify key features of pharmacogenomics as it relates to clinical validity and utility
Examine current use and barriers of pharmacogenomic testing
Interpret ethical and legal implications for clinical use
PGx testing offered at Absolute Genomics
Getting started

Speakers
Dr. Abbas Raza
Dr. Raza is an experienced operations executive with a demonstrated track record of success working in Clinical Diagnostics services, offering comprehensive expertise in Quality Control & Management (CLIA, CAP), Laboratory Operations (Pre-Analytical, Analytical, and Post-Analytical), Strategic Development, and Customer service. He has strong credentials (Ph.D. Autoimmune Diseases, University of Vermont, Post doctorate Infectious Diseases, University of Massachusetts Medical School) and is leading the education and professional advancement of staff at Absolute Genomics.

Kristen Petrasko
Kristen Petrasko graduated from Wilkes University in 2020 with a B.S. in Biology. She joined Absolute Genomics in September 2020, and has learned many skills including accessioning, DNA extraction, PCR testing, and data analysis.

Today is the day!! Please tune in at 1pm EST to our Sexual Health: Challenges and Solutions webinar! We can't wait to see everyone there!
Here is the link to get your free login https://lnkd.in/ey4y5Rtj

OASH: Office on Women's Health has provided a very informative fact sheet on STI's and Women's health. This page regards FAQs and more, check it out!
https://www.womenshealth.gov/a-z-topics/sexually-transmitted-infections #:~:text=How%20do%20STIs%20affect%20women,gonorrhea%20also%20can%20cause%20infertility
For more information about our STI and Women's Health panels please visit us at: www.absolutegenomic.com

https://lnkd.in/emtFcf-H.

Sexually transmitted infections | Office on Women's Health The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Despite the remarkable efficacy of COVID-19 vaccines, waning immunity and the emergence of SARS-CoV-2 variants such as Omicron represents a global health challenge. This study presents data from a study in nonhuman primates demonstrating durable protection against the Omicron BA.1 variant induced by a subunit SARS-CoV-2 vaccine comprising the receptor binding domain of the ancestral strain (RBD-Wu) on the I53-50 nanoparticle adjuvanted with AS03, which was recently authorized for use in individuals 18 years or older.

https://lnkd.in/gF_D7cs4

For more information on Covid-19 or how to order a RT-PCR Test Visit: www.absolutegenomics.com

Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine.

Chronic wound infections are a huge source of pain and suffering for many people. This review paper outlines mechanisms, diagnostic criteria, and therapeutic treatments of chronic wound infections.

https://mednexus.org/doi/full/10.1016/j.cjtee.2021.07.004 -2

For more information on wound infections, visit https://lnkd.in/gP3YT3ZZ

429 Internal Server Error

COVID-19 fungal infections cause severe illness, but comprehensive data in these infections are lacking. Here is an article from the IDSA about this issue.

https://lnkd.in/eTMw4Tpa

For more information about our covid panel please visit: www.absolutegenomics.com
#

Increased deaths from fungal infections during the COVID-19 pandemic—National Vital Statistics System, United States, January 2020–December 2021 AbstractBackground. COVID-19–associated fungal infections cause severe illness, but comprehensive data on disease burden are lacking. We analyzed US National Vi

A new, privately funded venture announced today it has recruited more than 20 top scientists and is pouring $15 million raised so far into Long Covid research, with plans to launch clinical trials of treatments as soon as possible.

https://lnkd.in/g5wQjsib

For more information on Covid, visit absolutegenomic.com

New private venture tackles the riddle of Long Covid—and aims to test treatments quickly Initiative focuses first on hypothesis that coronavirus lingers in patients

New study shows severe COVID-19 infections can create "Cytokine Storms", leading to very poor patient health and outcomes. See here how cytokines and the roll of a defect type 1 interferon (IFN-1) can lead to these issues.

https://lnkd.in/eeKY-iXs

For more general information on COVID-19 please visit:
https://lnkd.in/dnNFgmwc

Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19 The priming of macrophages by SARS-CoV-2-infected pDCs provokes an inflammatory response to microbial components in patient lungs.

“Pharmacogenomics in psychiatry has the most robust evidence to be useful for people who have depression, who are being treated with antidepressants, and who have failed to respond to at least one or more antidepressant trials”

https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2022.08.8.47
For more information on our PGx panel please visit our website www.absolutegenomic.com

Pharmacogenomic Testing May Help Achieve Better Patient Outcomes, Reduced Toxicity How a patient metabolizes specific psychiatric medications can be checked with pharmacogenomic testing. Researchers say the results may improve psychiatric treatment response for some patients.

Sexually transmitted infections present major and unique challenges for detection and treatment, in part because such infections and their diseases are often asymptomatic. Want to learn more about common STI diseases and how to get tested? Check out this educational webinar on Oct 27th. For free registration https://lnkd.in/ey4y5Rtj

https://lnkd.in/gV9uVdQz

"Most people who get an RSV infection will have mild illness and will recover in a week or two. Some people, however, are more likely to develop severe RSV infection and may need to be hospitalized. Examples of severe infections include bronchiolitis (an inflammation of the small airways in the lung) and pneumonia. RSV can also make chronic health problems worse. "

This time of year, many people are not only susceptible to COVID-19, but other respiratory illness as well. Anyone at any age is at risk.

For more information about our respiratory panel please visit us at: www.absolutegenomic.com # #

Learn about people at high risk for severe RSV infection. Some people, including infants and young children, older adults, and adults with chronic medical conditions, are more likely to develop severe RSV infection and may need to be hospitalized.

In severe cases of wound infection, a biofilm, which is a slimy film comprised of various bacteria, will sometimes form over the wound. This fascinating study proposes a potential treatment for antibiotic resistant biofilms.

https://www.frontiersin.org/articles/10.3389/fmicb.2021.749685/full

For more information about wound infections, visit https://lnkd.in/gP3YT3ZZ

Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin Infections caused by Gram-positive bacteria are a major public health problem due to their increasing resistance to antibiotics. Staphylococcus and Enterococcus species’ resistance and pathogenicity are enhanced by their ability to form biofilm. The biofilm lifestyle represents a significant obsta...